From Alphastreet - Earnings Decoded. Market Intelligence Delivered · AlphaStreet Newsdesk · · 30s
Jazz Pharmaceuticals Shares Drop 5.1%
Jazz Pharmaceuticals shares fell 5.1% amid sector-wide biotech selling.
In brief
Jazz Pharmaceuticals shares fell 5.1% amid sector-wide biotech selling. Jazz Pharmaceuticals shares dropped 5.1% on Thursday as biotechnology stocks fell due to sector-wide selling. Originally reported by Alphastreet - Earnings Decoded. Market Intelligence Delivered.
Jazz Pharmaceuticals Shares Drop
Jazz Pharmaceuticals plunged 5.1% on Thursday as a sector-wide selloff dragged down biotechnology stocks.
Sector Peers Also Declined
Two sector peers fell 4.4% and 3.3% on Thursday, indicating broad biotech sector selling.
Market Capitalization at $14.1 Billion
The stock’s market capitalization now stands at $14.1 billion following the decline.
The headline
Jazz Pharmaceuticals shares dropped 5.1% on Thursday as biotechnology stocks fell due to sector-wide selling.
